Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
IAC Express
|
2012 Issues
|
Issue 985
IAC Express: Weekly immunization news and information
Issue 985: March 27, 2012

TOP STORIES
VACCINE INFORMATION STATEMENTS
FEATURED RESOURCES
JOURNAL ARTICLES AND NEWSLETTERS CONFERENCES AND MEETINGS



TOP STORIES

CDC releases provisional ACIP recommendations for Tdap use in people age 65 and older
On March 21, CDC posted ACIP Provisional Tdap Recommendations on its website. Some of the content is reprinted below.

On February 22, 2012, the ACIP voted to recommend tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) for adults aged 65 years and older. . . .

Two Tdap vaccines are licensed in the United States.
  • Boostrix (GlaxoSmithKline Biologicals, Rixensart, Belgium) is approved for use in persons aged 10 years and older.
  • Adacel (Sanofi Pasteur, Toronto, Canada) is approved for use in persons aged 11 through 64 years.
Updated recommendation
  • For adults aged 19 years and older who previously have not received a dose of Tdap, a single dose of Tdap should be given.
  • Tdap should be administered regardless of interval since the last tetanus or diphtheria toxoid-containing vaccine.
  • Adults should receive a Tdap dose if the dose is recommended and no record of previous administration exists.
Guidance on use of Tdap products for adults aged 65 years and older
  • Providers should not miss an opportunity to vaccinate persons aged 65 years and older with Tdap, and may administer the vaccine that they have available.
  • When feasible, for adults aged 65 years and older, Boostrix should be used; however, either vaccine product administered to a person aged 65 years and older provides protection and is considered valid.
The PDF version is available here.

Back to top



CDC advises providers to use all the schedules and footnotes in the 2012 U.S. Childhood Immunization Schedule
CDC is advising vaccination providers to use all three pages of the 2012 U.S. Childhood Immunization Schedule as a single, cohesive document. That is, the three schedules and footnotes that make up the 2012 document should be used together, not separately.

To help providers do this, CDC has combined all three schedules and footnotes into a 4-page document titled Recommended Immunization Schedules for Persons Aged 0 Through 18 Years—United States, 2012.

Back to top



Spotlight on immunize.org: where you'll find information on upcoming immunization events and conferences
Looking for information about upcoming immunization-related conferences, meetings, courses, and webinars? Look no further. The Calendar of Events web section on immunize.org provides the details you need. For each event, the calendar listing includes the date, time, location, sponsor, and a link for additional information.

If you have a conference you would like included on IAC's calendar, please email janelle@immunize.org with the details.

Back to top


VACCINE INFORMATION STATEMENTS

IAC posts updated VISs for polio and Td/Tdap vaccines in six additional languages
IAC recently posted updated VISs for inactivated polio and Td/Tdap vaccines in these six languages: Armenian, Cambodian, Farsi (spoken in Bahrain, Iran, United Arab Emirates), Hmong, Korean, and Tagalog. IAC thanks the California Department of Public Health, Immunization Branch, for these six translations. The updated polio and Td/Tdap VISs are now available in 16 languages.
Visit IAC's VIS web section for VISs in more than 35 languages 

Back to top


FEATURED RESOURCES

Influenza vaccination is recommended for almost everyone, so please keep vaccinating
Influenza vaccination is recommended for everyone age 6 months and older, so please keep vaccinating your patients.

Following is a list of resources related to influenza disease and vaccination for healthcare professionals and the public.
Back to top


JOURNAL ARTICLES AND NEWSLETTERS

CDC publishes report on progress made toward global polio eradication in Africa in 2011
CDC published Progress Toward Global Polio Eradication—Africa, 2011 in the March 23 issue of MMWR (pages 190–194). A press summary of the article is reprinted below.

Interruption of wild poliovirus (WPV) transmission in Nigeria is critical to the successful eradication of polio in Africa. In 2011, 350 WPV cases were reported by 12 African countries, a 47 percent decrease from the 657 cases reported in 2010. Importation of WPV into 29 previously polio-free African countries during 2003–2011 led to reestablished WPV transmission in Angola, Chad, Democratic Republic of the Congo (DRC), and Sudan, though the last confirmed case in Sudan was in 2009. Since 2003, multiple polio outbreaks in Africa have been traced to importations from Nigeria, the only country in Africa in which transmission has never ceased. To successfully eradicate polio, it is critical to interrupt the transmission of WPV from Nigeria. Urgent action is needed to strengthen supplemental immunization responses throughout the region and particularly in the polio-affected countries of Nigeria, Chad, and DRC, and to maintain sensitive surveillance throughout Africa.

Back to top


CONFERENCES AND MEETINGS

Reminder: National Conference on Immunization and Health Coalitions planned for May 23–25 in New Orleans
The 10th National Conference on Immunization and Health Coalitions (NCIHC) will take place in New Orleans on May 23–25. NCIHC is the only conference solely dedicated to collaboration and partnership as a way to improve the health status of communities. It offers skills-building, tools, and practical examples to help local, state, and national organizations build and sustain successful partnerships.

Related Links

Information on conference registration
Tentative agenda

Back to top




About IAC Express 
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.
If you have trouble receiving or displaying IAC Express messages, visit our online help section.
IAC Express is supported in part by Grant No. U38IP000589 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: Baxter Healthcare Corp.; CSL Biotherapies; GlaxoSmithKline; MedImmune, Inc.; Merck Sharp & Dohme Corp.; Novartis Vaccines; Ortho Clinical Diagnostics, Inc.; Pfizer, Inc.; and sanofi pasteur.
IAC Express Disclaimer
ISSN: 1526-1786

Our mailing address is
Immunization Action Coalition
1573 Selby Ave, Ste 234
St. Paul, MN 55104


Copyright (C) 2012 Immunization Action Coalition
All rights reserved.
Subscribe Today: IAC Express, Needle Tips, and Vaccinate Adults: the up-to-date immunization information you need
IAC Express
IAC Express Home
2014 Issues
2013 Issues
2012 Issues
2011 Issues
2010 - 1997 Issues
Praise for IAC Express
Help
Disclaimer
Video of the Week
Video: Clarifying Meningococcal Booster Dose Recommendations
Clarifying Meningococcal Booster Dose Recommendations: In this Medscape expert video, Dr. Amanda Cohn (CDC, NCIRD) explains the rationale behind the new booster dose recommendation for adolescents and answers frequently asked questions about implementation.
Log-in required
Visit the VOTW archive
Issue Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
Publication Staff
Editor: Deborah L. Wexler, MD
Managing Editor: Dale Thompson, MA
Associate Editor: Teresa Anderson, DDS, MPH
Editorial Assistant: Janelle Tangonan Anderson
Additional Information
News & Information
Media coverage about vaccines and vaccine-preventable diseases
Calendar of Events
Conferences and meetings on immunization
Shop IAC
Record cards, laminated schedules and more
 
This page was reviewed on January 27, 2014
 
Immunization Action Coalition  •  1573 Selby Ave  •  St. Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.